FIRMAGON

In the US, FIRMAGON (degarelix systemic) is a member of the following drug classes: gonadotropin-releasing hormone antagonists, hormones/antineoplastics and is used to treat Prostate Cancer.

US matches:

• Firmagon

UK matches:

• Firmagon 120mg Injection (SPC)

Ingredient matches for FIRMAGON

Degarelix

Degarelix is reported as an ingredient of FIRMAGON in the following countries:

• Greece

Degarelix acetate (a derivative of Degarelix) is reported as an ingredient of FIRMAGON in the following countries:

• Austria


• France


• Germany


• Sweden


• Switzerland


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.